Quest Diagnostics
$233.33Change from previous close: +0.97%Absolute change: +$2.24
At a glance
- Revenue growth
- +11.78%
- 2025 vs 2024
- Net income growth
- +13.89%
- 2025 vs 2024
- Net margin
- 9.0%
- 2024: 8.8%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total revenue | 3,043 | 2,895 | 2,806 | 2,816 | 2,761 | — |
| Cost of revenue | 2,016 | 1,953 | 1,896 | 1,867 | 1,818 | — |
| Gross profit | 1,027 | 942 | 910 | 949 | 943 | — |
| Selling, general and administrative | 529 | 499 | 504 | 501 | 486 | — |
| Operating income | 459 | 404 | 386 | 386 | 438 | — |
| EBIT | 480 | 399 | 397 | 397 | 453 | — |
| EBITDA | 626 | 546 | 542 | 539 | 596 | — |
| Interest expense | 68.0 | 65.0 | 67.0 | 69.0 | 69.0 | — |
| Pre-tax income | 412 | 334 | 330 | 328 | 384 | — |
| Income tax | 88.0 | 74.0 | 81.0 | 77.0 | 97.0 | — |
| Net income | 320 | 252 | 245 | 245 | 282 | — |
| Net income to common shareholders | 319 | 251 | 245 | 243 | 281 | — |
| Basic EPS | 2.88 | 2.27 | 2.21 | 2.18 | 2.51 | — |
| Diluted EPS | 2.84 | 2.24 | 2.18 | 2.16 | 2.47 | — |
| Average shares (basic) | 111 | 110 | 111 | 112 | 112 | — |
| Average shares (diluted) | 112 | 112 | 112 | 113 | 113 | — |